Atossa Therapeutics
ATOS
$1.54
Share price
5.48%
Change (1 day)
116.90%
Change (1 year)
Categories
Atossa Therapeutics (ATOS) - Total debt
Total debt on the balance sheet as of December 2021 : N/A
According to Atossa Therapeutics's latest financial reports the company's total debt is N/A. A company’s total debt is the sum of all current and non-current debts.
Atossa Therapeutics - Total debt on balance sheet (from 2010 to 2021)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2021-12-31 | $N/A | -100% |
| 2020-12-31 | $0.01 M | -64.34% |
| 2019-12-31 | $0.05 M | |
| 2018-12-31 | $N/A | |
| 2014-12-31 | $0.12 M | 707.95% |
| 2013-12-31 | $0.01 M | |
| 2012-12-31 | $N/A | -100% |
| 2011-12-31 | $1 M | 431.79% |
| 2010-12-31 | $0.18 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | N/A | 🇺🇸 USA |
 Quest Diagnostics
DGX | $5.35 B | N/A | 🇺🇸 USA |
 LabCorp LH | $5.96 B | N/A | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | N/A | N/A | 🇺🇸 USA |
 NeoGenomics
NEO | $0.60 B | N/A | 🇺🇸 USA |
 Enzo Biochem ENZ | $7.18 M | N/A | 🇺🇸 USA |